Khan, H. Y., Ge, J., Nagasaka, M., Aboukameel, A., Mpilla, G., Muqbil, I., . . . Sukari, A. (2019). Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance. Int J Mol Sci.
Chicago-stil citatKhan, Husain Yar, et al. "Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance." Int J Mol Sci 2019.
MLA-referensKhan, Husain Yar, et al. "Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance." Int J Mol Sci 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.